HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease-Reference-Cited by-同舟云学术

HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease

Published:2016-08-25 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Fujita Kyota,Motoki Kazumi,Tagawa Kazuhiko,Chen Xigui,Hama Hiroshi,Nakajima Kazuyuki,Homma Hidenori,Tamura Takuya,Watanabe Hirohisa,Katsuno Masahisa,Matsumi Chiemi,Kajikawa Masunori,Saito Takashi,Saido Takaomi,Sobue Gen,Miyawaki Atsushi,Okazawa Hitoshi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31895.pdf

Reference61 articles.

1. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356, doi:10.1126/science.1072994 (2002).

2. Doody, R. S. et al. A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N Engl J Med 369, 341–350, doi:10.1056/NEJMoa1210951 (2013).

3. Doody, R. S., Farlow, M., Aisen, P. S., Committee, A. s. D. C. S. D. A. & Publication. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer’s disease. N Engl J Med 370, 1460, doi:10.1056/NEJMc1402193 (2014).

4. Selkoe, D. J. Resolving controversies on the path to Alzheimer’s therapeutics. Nat Med 17, 1060–1065, doi:10.1038/nm.2460 (2011).

5. Golde, T. E., Schneider, L. S. & Koo, E. H. Anti-aβ therapeutics in Alzheimer’s disease: the need for a paradigm shift. Neuron 69, 203–213, doi:10.1016/j.neuron.2011.01.002 (2011).

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate immune sensing of cell death in disease and therapeutics;Nature Cell Biology;2024-09

2. Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates;Heliyon;2024-08

3. Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvability;Frontiers in Cell and Developmental Biology;2024-07-12

4. Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy;International Journal of Molecular Sciences;2024-07-09

5. Asymptomatic herpes simplex virus brain infection elicits cellular senescence phenotypes in the central nervous system of mice suffering multiple sclerosis-like disease;Communications Biology;2024-07-04